119 related articles for article (PubMed ID: 36938873)
1. P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer.
Röbeck P; Xu L; Ahmed D; Dragomir A; Dahlman P; Häggman M; Ladjevardi S
Prostate; 2023 Jun; 83(9):831-839. PubMed ID: 36938873
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
6. Validation of the prognostic value of a three-gene signature and clinical parameters-based risk score in prostate cancer patients.
Saemundsson A; Xu LD; Meisgen F; Cao R; Ahlgren G
Prostate; 2023 Sep; 83(12):1133-1140. PubMed ID: 36988135
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
[TBL] [Abstract][Full Text] [Related]
8. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
[TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.
Hambrock T; Hoeks C; Hulsbergen-van de Kaa C; Scheenen T; Fütterer J; Bouwense S; van Oort I; Schröder F; Huisman H; Barentsz J
Eur Urol; 2012 Jan; 61(1):177-84. PubMed ID: 21924545
[TBL] [Abstract][Full Text] [Related]
11. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
[TBL] [Abstract][Full Text] [Related]
12. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
[TBL] [Abstract][Full Text] [Related]
13. A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
Koie T; Mitsuzuka K; Narita S; Yoneyama T; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C
Scand J Urol; 2015 Apr; 49(2):103-7. PubMed ID: 25165894
[TBL] [Abstract][Full Text] [Related]
14. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
[TBL] [Abstract][Full Text] [Related]
15. Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.
Marra G; Eldred-Evans D; Challacombe B; Van Hemelrijck M; Polson A; Pomplun S; Foster CS; Brown C; Cahill D; Gontero P; Popert R; Muir G
Urol Int; 2017; 99(2):168-176. PubMed ID: 28768264
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy.
Zhang J; Xiu J; Dong Y; Wang M; Han X; Qin Y; Huang Z; Cai S; Yuan X; Liu Q
Mol Med Rep; 2014 May; 9(5):1989-97. PubMed ID: 24584266
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens.
Altay B; Kefi A; Nazli O; Killi R; Semerci B; Akar I
Urol Int; 2001; 67(1):14-8. PubMed ID: 11464109
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
20. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]